These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 31053500)
1. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. Sun Q; Li J; Jin B; Wang T; Gu J Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500 [TBL] [Abstract][Full Text] [Related]
2. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
3. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041 [TBL] [Abstract][Full Text] [Related]
4. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Lin L; Lu B; Yu J; Liu W; Zhou A Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
6. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
7. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Meng FL; Wang W; Jia WD Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312 [TBL] [Abstract][Full Text] [Related]
9. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
10. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma. Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma. El-Hamouly MS; Azzam AA; Ghanem SE; El-Bassal FI; Shebl N; Shehata AMF Mol Biol Rep; 2019 Dec; 46(6):5759-5765. PubMed ID: 31471732 [TBL] [Abstract][Full Text] [Related]
12. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
13. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493 [TBL] [Abstract][Full Text] [Related]
14. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening. Jiang L; Li X; Cheng Q; Zhang BH Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380 [TBL] [Abstract][Full Text] [Related]
15. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
16. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Yin J; Hou P; Wu Z; Wang T; Nie Y Tumour Biol; 2015 Jun; 36(6):4501-7. PubMed ID: 25618599 [TBL] [Abstract][Full Text] [Related]
17. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Li L; Guo Z; Wang J; Mao Y; Gao Q Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399 [TBL] [Abstract][Full Text] [Related]
18. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450 [TBL] [Abstract][Full Text] [Related]
19. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288 [TBL] [Abstract][Full Text] [Related]
20. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]